Assisted Reproductive Therapy Market by Technique (Artificial Insemination, In-Vitro Fertilization and Frozen Embryo Transfer), by Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor), by End User (Hospitals and Fertility Clinics), - Global Outlook & Forecast 2022-2030
- Category: Healthcare
- Published Date: Sep 2022
- Publisher: Growth Plus Reports
- Pages: 117
The Assisted Reproductive Therapy Market is predicted to reach US$ by 2030 from US$ 19.5 billion in 2021, and to grow at a CAGR of 8.5% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Technique (Artificial Insemination, In-Vitro Fertilization and Frozen Embryo Transfer), by Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor), by End User (Hospitals and Fertility Clinics)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
CARE Fertility, Bloom IVF Centre, Monash IVF Group, European Sperm Bank, Apollo Hospitals Enterprise Ltd., Carolinas Fertility Centre, California Cryobank, INVO Bioscience, Ferring B.V., NOVA IVF, and Hamilton Thorne, Inc. among others
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Technique (Artificial Insemination, In-Vitro Fertilization and Frozen Embryo Transfer), by Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor), by End User (Hospitals and Fertility Clinics)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
CARE Fertility, Bloom IVF Centre, Monash IVF Group, European Sperm Bank, Apollo Hospitals Enterprise Ltd., Carolinas Fertility Centre, California Cryobank, INVO Bioscience, Ferring B.V., NOVA IVF, and Hamilton Thorne, Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY REGION
North America Assisted Reproductive Therapy
1. North America Assisted Reproductive Therapy , by Country
1. US
2. Canada
1. North America Assisted Reproductive Therapy , by Product
2. North America Assisted Reproductive Therapy , by Type
3. North America Assisted Reproductive Therapy , by Gender
4. North America Assisted Reproductive Therapy , by Sales Channel
3. Europe Assisted Reproductive Therapy
1. Europe Assisted Reproductive Therapy , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Assisted Reproductive Therapy , by Product
3. Europe Assisted Reproductive Therapy , by Type
4. Europe Assisted Reproductive Therapy , by Gender
5. Europe Assisted Reproductive Therapy , by Sales Channel
4. Asia Pacific Assisted Reproductive Therapy
1. Asia Pacific Assisted Reproductive Therapy , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Assisted Reproductive Therapy , by product
3. Asia Pacific Assisted Reproductive Therapy , by Type
4. Asia Pacific Assisted Reproductive Therapy , by Gender
5. Asia Pacific Assisted Reproductive Therapy , by Sales Channel
5. Rest of the World Assisted Reproductive Therapy
1. Rest of the World Assisted Reproductive Therapy , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Assisted Reproductive Therapy , by Product
3. Rest of the World Assisted Reproductive Therapy , by Type
4. Rest of the World Assisted Reproductive Therapy , by Gender
5. Rest of the World Assisted Reproductive Therapy , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 58
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Assisted Reproductive Therapy - ANALYSIS & FORECAST, BY REGION
North America Assisted Reproductive Therapy
1. North America Assisted Reproductive Therapy , by Country
1. US
2. Canada
1. North America Assisted Reproductive Therapy , by Product
2. North America Assisted Reproductive Therapy , by Type
3. North America Assisted Reproductive Therapy , by Gender
4. North America Assisted Reproductive Therapy , by Sales Channel
3. Europe Assisted Reproductive Therapy
1. Europe Assisted Reproductive Therapy , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Assisted Reproductive Therapy , by Product
3. Europe Assisted Reproductive Therapy , by Type
4. Europe Assisted Reproductive Therapy , by Gender
5. Europe Assisted Reproductive Therapy , by Sales Channel
4. Asia Pacific Assisted Reproductive Therapy
1. Asia Pacific Assisted Reproductive Therapy , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Assisted Reproductive Therapy , by product
3. Asia Pacific Assisted Reproductive Therapy , by Type
4. Asia Pacific Assisted Reproductive Therapy , by Gender
5. Asia Pacific Assisted Reproductive Therapy , by Sales Channel
5. Rest of the World Assisted Reproductive Therapy
1. Rest of the World Assisted Reproductive Therapy , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Assisted Reproductive Therapy , by Product
3. Rest of the World Assisted Reproductive Therapy , by Type
4. Rest of the World Assisted Reproductive Therapy , by Gender
5. Rest of the World Assisted Reproductive Therapy , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 58
no record found